MedPath
HSA Approval

MECLOSIL TABLET

SIN10845P

MECLOSIL TABLET

MECLOSIL TABLET

March 25, 1999

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSUNWARD PHARMACEUTICAL PRIVATE LIMITED
Licence HolderSUNWARD PHARMACEUTICAL PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Pharmacy Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

A02AF02

ordinary salt combinations and antiflatulents

Manufacturer Information

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

SUNWARD PHARMACEUTICAL PRIVATE LIMITED

Active Ingredients

DICYCLOMINE HCl

2.5 mg

Dicyclomine

SIMETHICONE

10 mg

Simethicone

ALUMINIUM HYDROXIDE-MAGNESIUM CARBONATE CO-DRIED GEL

325 mg

Aluminium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

MECLOSIL TABLET - HSA Approval | MedPath